These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 14650241)

  • 1. Proteomics and drug discovery.
    Jain KK
    Contrib Nephrol; 2004; 141():308-27. PubMed ID: 14650241
    [No Abstract]   [Full Text] [Related]  

  • 2. Discovery and development of biopharmaceuticals: current issues.
    Strohl WR; Knight DM
    Curr Opin Biotechnol; 2009 Dec; 20(6):668-72. PubMed ID: 19896824
    [No Abstract]   [Full Text] [Related]  

  • 3. Proteomics profile of cellular response to chiral drugs: prospects for pharmaceutical applications.
    Bun Ching C; Zhang J; Sui J; Ning Chen W
    Proteomics; 2010 Feb; 10(4):888-93. PubMed ID: 19953539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current Challenges and Potential Opportunities for the Pharmaceutical Sciences to Make Global Impact: An FIP Perspective.
    Tucker G; DeSilva B; Dressman J; Ito M; Kumamoto T; Mager D; Mahler HC; Maitland-van der Zee AH; Pauletti GM; Sasaki H; Shah V; Tang D; Ward M
    J Pharm Sci; 2016 Sep; 105(9):2489-2497. PubMed ID: 26886325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The proteomics bottleneck: strategies for preliminary validation of potential biomarkers and drug targets.
    Bodovitz S; Joos T
    Trends Biotechnol; 2004 Jan; 22(1):4-7. PubMed ID: 14690616
    [No Abstract]   [Full Text] [Related]  

  • 6. Proteomics approach to illustrate drug action mechanisms.
    Wang Y; Chiu JF; He QY
    Curr Drug Discov Technol; 2006 Sep; 3(3):199-209. PubMed ID: 17311565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug target deconvolution by chemical proteomics.
    Raida M
    Curr Opin Chem Biol; 2011 Aug; 15(4):570-5. PubMed ID: 21763176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of new biotechnology to design rational drugs against newly defined targets.
    Salfeld JG
    Best Pract Res Clin Rheumatol; 2004 Feb; 18(1):81-95. PubMed ID: 15123039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In biomarkers we trust?
    Baker M
    Nat Biotechnol; 2005 Mar; 23(3):297-304. PubMed ID: 15765081
    [No Abstract]   [Full Text] [Related]  

  • 10. Comprehensive survey of chemical libraries for drug discovery and chemical biology: 2006.
    Dolle RE; Le Bourdonnec B; Goodman AJ; Morales GA; Salvino JM; Zhang W
    J Comb Chem; 2007; 9(6):855-902. PubMed ID: 17877417
    [No Abstract]   [Full Text] [Related]  

  • 11. Proteomic approaches in drug discovery and development.
    Soares HD; Williams SA; Snyder PJ; Gao F; Stiger T; Rohlff C; Herath A; Sunderland T; Putnam K; White WF
    Int Rev Neurobiol; 2004; 61():97-126. PubMed ID: 15482813
    [No Abstract]   [Full Text] [Related]  

  • 12. Biotechnology partnerships--medicine for an ailing industry?
    DeLamarter J
    Nat Biotechnol; 2003 Aug; 21(8):847-8. PubMed ID: 12894192
    [No Abstract]   [Full Text] [Related]  

  • 13. Crystal structures of drugs: advances in determination, prediction and engineering.
    Datta S; Grant DJ
    Nat Rev Drug Discov; 2004 Jan; 3(1):42-57. PubMed ID: 14708020
    [No Abstract]   [Full Text] [Related]  

  • 14. Recent development and application of virtual screening in drug discovery: an overview.
    Hou T; Xu X
    Curr Pharm Des; 2004; 10(9):1011-33. PubMed ID: 15078130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Raman spectroscopy in pharmaceutical product design.
    Paudel A; Raijada D; Rantanen J
    Adv Drug Deliv Rev; 2015 Jul; 89():3-20. PubMed ID: 25868453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. March of the synthesis machines.
    Sanderson K
    Nat Rev Drug Discov; 2015 May; 14(5):299-300. PubMed ID: 25924572
    [No Abstract]   [Full Text] [Related]  

  • 17. The hunt for a new drug: five views from the inside.
    Mervis J
    Science; 2005 Jul; 309(5735):722. PubMed ID: 16051781
    [No Abstract]   [Full Text] [Related]  

  • 18. Proteomics in the pharmaceutical and biotechnology industry: a look to the next decade.
    Lill JR; Mathews WR; Rose CM; Schirle M
    Expert Rev Proteomics; 2021 Jul; 18(7):503-526. PubMed ID: 34320887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expanding proteomics into the analysis of chiral drugs.
    Sui J; Zhang J; Ching CB; Chen WN
    Mol Biosyst; 2009 Jun; 5(6):603-8. PubMed ID: 19462017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery and Development of Novel Drugs.
    Erakovic Haber V; Spaventi R
    Prog Mol Subcell Biol; 2017; 55():91-104. PubMed ID: 28238036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.